Science is at the core of Altria’s approach to Tobacco Harm Reduction. Our investment in research and technology supports our work on smoke-free platforms and the science needed for product applications submitted to the Food and Drug Administration (FDA).
Our regulatory science team generates the scientific evidence needed to demonstrate that certain tobacco products result in lower exposure to harmful compounds or are lower risk when compared to conventional cigarettes. We’ve been at the forefront of developing new methodologies to assess the health impact of potentially reduced-risk tobacco products.
Our scientists continue to publish extensively in this area. We share our research on this website and regularly invite scientific review from, and dialogue with, scientists and the public health and regulatory communities. Learn more about our public Communications & Engagement.